FDA (Drugs) recall action 65707
The FDA (Drugs) publishes a recall like this one as 273 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 273 pages.
Labeling:Label Mixup; sulfaSALAzine Tablet, 500 mg may be potentially mislabeled as HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD46265_7, EXP: 5/15/2014.
Labeling:Label Mixup; CRANBERRY Tablet, 450 mg may be potentially mislabeled as METOPROLOL SUCCINATE ER, Tablet, 200 mg, NDC 62037083301, Pedigree: AD73652_13, EXP: 5/30/2014.
Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 2000 units may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD46312_34, EXP: 5/16/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 13811051410, Pedigree: AD65314_1, EXP: 5/24/2014; RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003538, EXP: 6/21/2014; LEVOTHYROXINE SODIUM, Tablet, 175
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Aidapak Services is recalling Vitamin B Complex capsules because they may be mislabeled as Sodium Chloride tablets. The recall covers 2,398 capsules distributed in four western states.
Aidapak Services, LLC is recalling Torsemide 10 mg tablets that may be mislabeled as Mexiletine HCl 200 mg capsules.
Aidapak Services is recalling Omeprazole/Sodium Bicarbonate capsules because they may be mislabeled as Cyanocobalamin or Omega-3 fatty acid products.
Aidapak Services is recalling Calcium Citrate tablets that may be mislabeled as Tizanidine HCl. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling Quetiapine Fumarate 25 mg tablets because they may be mislabeled as Chlordiazepoxide HCl capsules.
Aidapak Services, LLC is recalling 10,819 tablets of Calcium Carbonate +D3 because they may be mislabeled as Digoxin or Amantadine HCl.
Aidapak Services, LLC is recalling Itraconazole capsules because they may be mislabeled as Famciclovir tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling 402 Metoprolol Tartrate tablets because they may be mislabeled as Docusate Sodium capsules.
Aidapak Services, LLC is recalling D-Alpha Tocopheryl Acetate capsules because they may be mislabeled as Cyanocobalamin tablets.
Aidapak Services, LLC is recalling Metoprolol Succinate ER 200 mg tablets due to a potential labeling mixup. The affected repacked drugs were distributed in four western states.
Aidapak Services is recalling Omeprazole/Sodium Bicarbonate capsules because they may be mislabeled as Benzocaine/Menthol lozenges. The FDA classifies this as a Class II recall.
Aidapak Services, LLC is recalling Hydralazine HCL 25 mg tablets because they may be mislabeled as Docusate Calcium 240 mg capsules.
Aidapak Services is recalling Rifaximin 200 mg tablets that may be mislabeled as Toprol 25 mg. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Quetiapine Fumarate 25 mg tablets because they may be mislabeled as multivitamin or aspirin products.
Aidapak Services is recalling Solifenacin Succinate 5 mg tablets because they may be mislabeled as Bromocriptine Mesylate 2.5 mg.
Aidapak Services, LLC is recalling Benzoicaine/Menthol lozenges because they may be mislabeled as Cholecalciferol/Calcium/Phosphorus tablets.
Aidapak Services, LLC is recalling specific lots of Colchicine 0.6 mg tablets because they may be mislabeled as other medications.
Aidapak Services is recalling Galantamine HBr ER capsules because they may be mislabeled as Famotidine tablets.
Aidapak Services, LLC is recalling Pseudoephedrine HCL 60 mg tablets because they may be mislabeled as Repaglinide 1 mg tablets.
Aidapak Services is recalling 400 mg ibuprofen tablets that may be mislabeled as 325 mg aspirin. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Allopurinol 300 mg tablets because they may be mislabeled as Cholecalciferol 400 units.
Aidapak Services, LLC is recalling guaiFENesin ER tablets because they may be mislabeled as fenofibrate or glyburide. The error poses a risk of patients taking the wrong medication.
Aidapak Services is recalling RANOLAZINE ER 500 mg tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling TACROLIMUS Capsules, 1 mg, because they may be mislabeled as LEVOTHYROXINE SODIUM Tablets, 125 mcg.
Aidapak Services is recalling 1,013 sodium bicarbonate tablets that may be mislabeled as nicotine polacrilex lozenges.